UA Drug Discovery Startup Lands $4M to Target Cancer

By: Kyle Macdonald, COO of Silicon Oasis Category : Health Tech , Funding Rounds A new Arizona biotech startup is making waves — and it's born out of the University of Arizona. Branch Therapeutics , co-founded by University of Arizona and University of Dundee researchers, just raised a$4 million seed round to develop oral cancer treatments . Their lead candidate targets colorectal cancer, with plans to expand into liver and breast cancers. This is a big win not just for the company, but for Arizona’s innovation ecosystem — and a clear signal that serious biotech is gaining traction here. We break down: How the deal came together The role Tech Launch Arizona played Why this matters for the future of life science startups in the state Read the full breakdown in this month’s issue of the Silicon Oasis Magazine .

Subscribe here.